Drugs / MANIDIPINE 6300

Trials 3

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT07091136 Aug 2025 → Aug 2026 overdue aortic valve calcification Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Not yet recruiting No outcome recorded
Phase 31 trial · 1 missed
Phase 3 NCT00157586 Feb 2002 → Jun 2008 type 2 diabetes mellitus Mario Negri Institute for Pharmacological Research Completed Missed primary
Phase 41 trial
Phase 4 NCT03106597 Aug 2015 → May 2018 essential hypertension Korea University Guro Hospital Terminated No outcome recorded Stop: Enrollment
Comparator or background therapy2 trials
Phase 3 NCT00627952 Comparator Nov 2007 → Dec 2008 hypertensive disorder University of Erlangen-Nürnberg Medical School Completed No outcome recorded
Phase 4 NCT00741585 Comparator Sep 2008 → Jun 2018 chronic kidney disease, essential hypertension, stroke disorder University of Vigo Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as MANIDIPINE 6300 ChEMBL registry synonym — accepted as the source's own label CHEMBL1085699 ↗
Known as Artedil ChEMBL registry synonym — accepted as the source's own label CHEMBL1085699 ↗
Known as Franidipine ChEMBL registry synonym — accepted as the source's own label CHEMBL1085699 ↗
Known as Madipine Tab(Manidipine Hydrochloride) 20mg (CJ) “Madipine Tab(Manidipine Hydrochloride) 20mg (CJ)” NCT03106597 ↗
Known as manidipine “Manidipine” NCT00741585 ↗
4

NCT03106597 ↗

NCT07091136 ↗

NCT00627952 ↗

NCT00157586 ↗

Known as Manidipino ChEMBL registry synonym — accepted as the source's own label CHEMBL1085699 ↗
Action Inhibit “third-generation dihydropyridine calcium channel blockers” PMID 21931073 ↗ Sep 2011
Modality Small molecule — CHEMBL1085699 ↗